Posted inTAP

The Oxymoron of House Democratic Governance

It was not a memorable week in the annals of Democratic policymaking. Earlier this week, I wrote a preview of H.R. 3, Nancy Pelosi’s drug-pricing bill, seen as the signature effort of this year’s legislative session. I mentioned in there that the summary, still riddled with questions, probably represented the high-water mark for the bill, […]

Gift this article